Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
This study is ongoing, but not recruiting participants.
Study NCT00002850 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infection
Additional conditions recognized in this trial
Communicable Diseases
Multiple Myeloma
Neoplasms
Neoplasms, Plasma Cell
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
ciprofloxacin
ofloxacin
trimethoprim-sulfamethoxazole
Additional drug interventions recognized in this trial
Anti-Bacterial Agents
Sulfamethoxazole
Trimethoprim
Trimethoprim-Sulfamethoxazole Combination
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
University of Rochester
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Back to top of Main Content
